Avalon GloboCare Corp. Faces Potential Delisting from Nasdaq Due to Non-Compliance with Equity Requirements

Reuters
24 May
<a href="https://laohu8.com/S/ALBT">Avalon GloboCare</a> Corp. Faces Potential Delisting from Nasdaq Due to Non-Compliance with Equity Requirements

Avalon GloboCare Corp. has announced that it received a notice from the Nasdaq Stock Market on May 22, 2025, regarding its non-compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market. The company's reported stockholders' equity stands at negative $3,891,270, falling short of the required $2.5 million. As a result, Avalon GloboCare has until July 7, 2025, to submit a compliance plan to Nasdaq. If the plan is accepted, the company could receive an extension until November 18, 2025, to meet the listing standards. Failure to comply may result in delisting, which would significantly impact the company's trading and financial operations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalon Globocare Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-047391), on May 23, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10